Publicaciones en las que colabora con Javier Chao Pellicer (12)

2024

  1. Exploring therapeutic approaches against Naegleria fowleri infections through the COVID box

    International Journal for Parasitology: Drugs and Drug Resistance, Vol. 25

  2. Flucofuron as a Promising Therapeutic Agent against Brain-Eating Amoeba

    ACS Infectious Diseases, Vol. 10, Núm. 6, pp. 2063-2073

  3. Influence of salt and temperature in the growth of pathogenic free-living amoebae

    Frontiers in Microbiology, Vol. 15

  4. Synthesis and Biological Evaluation of Cyanoacrylamides and 5-Iminopyrrol-2-Ones Against Naegleria fowleri

    ACS Infectious Diseases, Vol. 10, Núm. 9, pp. 3332-3345

2023

  1. Chamigrane-Type Sesquiterpenes from Laurencia dendroidea as Lead Compounds against Naegleria fowleri

    Marine Drugs, Vol. 21, Núm. 4

  2. Cyanomethyl Vinyl Ethers Against Naegleria fowleri

    ACS Chemical Neuroscience, Vol. 14, Núm. 11, pp. 2123-2133

  3. Identification and characterization of novel marine oxasqualenoid yucatecone against Naegleria fowleri

    International Journal for Parasitology: Drugs and Drug Resistance, Vol. 22, pp. 61-71

  4. Marine Meroterpenoids Isolated from Gongolaria abies-marina Induce Programmed Cell Death in Naegleria fowleri

    Pharmaceuticals, Vol. 16, Núm. 7

  5. Repurposing of Nitroxoline as an Alternative Primary Amoebic Meningoencephalitis Treatment

    Antibiotics, Vol. 12, Núm. 8

2022

  1. A Fluorometric Assay for the In Vitro Evaluation of Activity against Naegleria fowleri Cysts

    Microbiology spectrum, Vol. 10, Núm. 4, pp. e0051522

  2. Sesquiterpene lactones as potential therapeutic agents against Naegleria fowleri

    Biomedicine and Pharmacotherapy, Vol. 147

2021

  1. Naphthyridine derivatives induce programmed cell death in naegleria fowleri

    Pharmaceuticals, Vol. 14, Núm. 10